Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock

(CYCCP) Trade

By |

Profile

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. The company earns the majority of its revenue from the United Kingdom.

Contact Information

Website: www.cyclacel.com
Email: ir@cyclacel.com
Main Phone: +1 908 517-7330
Address: 200 Connell Drive
Address 2: Suite 1500
State: NJ
City / Town: Berkeley Heights
Country: USA
Postal Code: 07922

Issuer Information

Exchange: NSC
CEO: Spiro Rombotis
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News



Gathering Data... Please wait

Profile

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. The company earns the majority of its revenue from the United Kingdom.

Contact Information

Website: www.cyclacel.com
Email: ir@cyclacel.com
Main Phone: +1 908 517-7330
Address: 200 Connell Drive
Address 2: Suite 1500
State: NJ
City / Town: Berkeley Heights
Country: USA
Postal Code: 07922

Issuer Information

Exchange: NSC
CEO: Spiro Rombotis
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 4.61 $ 0. (0.00%)
Last Price 4.61 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 4.61
Last Trade Volume 0 52 Wk Hi 7.00 52 Wk Low 4.31
Market Cap 1.5 mi Ex-Div Date Div Rate 0.60 Yield 13.0100
Shares 335,273.00 EPS (TTM) N/A PE Ratio N/A Exchange NCM